Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 58

Related Articles by Review for PubMed (Select 20467288)

1.

Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study.

Martínez E, Larrousse M, Llibre JM, Gutiérrez F, Saumoy M, Antela A, Knobel H, Murillas J, Berenguer J, Pich J, Pérez I, Gatell JM; SPIRAL Study Group.

AIDS. 2010 Jul 17;24(11):1697-707. doi: 10.1097/QAD.0b013e32833a608a. Erratum in: AIDS. 2010 Oct 23;24(16):2602.

PMID:
20467288
3.

Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and results.

Taiwo B, Murphy RL, Katlama C.

Drugs. 2010 Sep 10;70(13):1629-42. doi: 10.2165/11538020-000000000-00000. Review.

PMID:
20731472
4.

Raltegravir: in treatment-naive patients with HIV-1 infection.

Croxtall JD, Scott LJ.

Drugs. 2010 Mar 26;70(5):631-42. doi: 10.2165/11204590-000000000-00000. Review.

PMID:
20329808
5.

HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review.

Bierman WF, van Agtmael MA, Nijhuis M, Danner SA, Boucher CA.

AIDS. 2009 Jan 28;23(3):279-91. doi: 10.1097/QAD.0b013e32831c54e5. Review.

PMID:
19114854
6.

First-line raltegravir. No evidence of comparative effectiveness.

[No authors listed]

Prescrire Int. 2010 Nov;19(110):248-50. Review.

PMID:
21284354
7.

[Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens].

Kravchenko AV.

Ter Arkh. 2010;82(11):27-32. Review. Russian.

PMID:
21381345
8.

[Darunavir in patients with advanced HIV and multiresistance. The POWER, DUET and BENCHMRK studies].

Arazo Garcés P, Omiste Sanvicente T.

Enferm Infecc Microbiol Clin. 2008 Oct;26 Suppl 10:23-31. Review. Spanish.

PMID:
19195456
9.

Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomized controlled trials.

Carey D, Amin J, Boyd M, Petoumenos K, Emery S.

J Antimicrob Chemother. 2010 Sep;65(9):1878-88. doi: 10.1093/jac/dkq231. Epub 2010 Jun 16. Review.

10.

The use of HIV-1 integrase inhibitors in antiretroviral naive patients.

Lennox JL.

Curr Opin HIV AIDS. 2012 Sep;7(5):409-14. doi: 10.1097/COH.0b013e3283562a27. Review.

PMID:
22789985
11.

[Genetic barrier to antiretroviral drug-resistance. Focus on raltegravir, the first integrase inhibitor].

Delaugerre C.

Med Mal Infect. 2010 Sep;40 Suppl 1:S1-10. doi: 10.1016/S0399-077X(10)70001-9. Review. French.

PMID:
20800182
12.

Darunavir: an effective protease inhibitor for HIV-infected patients.

Phung BC, Yeni P.

Expert Rev Anti Infect Ther. 2011 Jun;9(6):631-43. doi: 10.1586/eri.11.48. Review.

PMID:
21692667
13.

[Role of the new molecules in antiretroviral therapy. Position of raltegravir].

Arribas JR.

Enferm Infecc Microbiol Clin. 2008 Nov;26 Suppl 12:53-9. Review. Spanish.

PMID:
19572427
14.

Cost-effectiveness of raltegravir in HIV/AIDS.

Chaudhary MA, Elbasha EH, Kumar RN, Nathanson EC.

Expert Rev Pharmacoecon Outcomes Res. 2011 Dec;11(6):627-39. doi: 10.1586/erp.11.79. Review.

PMID:
22098278
15.

Raltegravir: a review of its use in the management of HIV-1 infection in children and adolescents.

Perry CM.

Paediatr Drugs. 2014 Feb;16(1):91-100. doi: 10.1007/s40272-013-0058-9. Review.

PMID:
24277175
16.

A meta-analysis of the efficacy and safety of unboosted atazanavir compared with ritonavir-boosted protease inhibitor maintenance therapy in HIV-infected adults with established virological suppression after induction.

Baril J, Conway B, Giguère P, Ferko N, Hollmann S, Angel JB.

HIV Med. 2014 May;15(5):301-10. doi: 10.1111/hiv.12118. Epub 2013 Dec 9. Review.

PMID:
24314017
17.

Role of raltegravir in HIV-1 management.

Rokas KE, Bookstaver PB, Shamroe CL, Sutton SS, Millisor VE, Bryant JE, Weissman SB.

Ann Pharmacother. 2012 Apr;46(4):578-89. doi: 10.1345/aph.1Q616. Epub 2012 Apr 10. Review.

PMID:
22496475
18.

Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium.

Nguyen BY, Isaacs RD, Teppler H, Leavitt RY, Sklar P, Iwamoto M, Wenning LA, Miller MD, Chen J, Kemp R, Xu W, Fromtling RA, Vacca JP, Young SD, Rowley M, Lower MW, Gottesdiener KM, Hazuda DJ.

Ann N Y Acad Sci. 2011 Mar;1222:83-9. doi: 10.1111/j.1749-6632.2011.05972.x. Review.

PMID:
21434946
19.

Protease inhibitor monotherapy as maintenance regimen in patients with HIV infection.

Calza L, Manfredi R.

Curr HIV Res. 2012 Dec;10(8):661-72. Review.

PMID:
23016538
20.

Clinical use of HIV integrase inhibitors: a systematic review and meta-analysis.

Messiaen P, Wensing AM, Fun A, Nijhuis M, Brusselaers N, Vandekerckhove L.

PLoS One. 2013;8(1):e52562. doi: 10.1371/journal.pone.0052562. Epub 2013 Jan 9. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk